» Articles » PMID: 15834867

Comparison of Affinity Chromatography and Adsorption to Vaccinia Virus Recombinant Infected Cells for Depletion of Antibodies Directed Against Respiratory Syncytial Virus Glycoproteins Present in a Human Immunoglobulin Preparation

Overview
Journal J Med Virol
Specialty Microbiology
Date 2005 Apr 19
PMID 15834867
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies directed against human respiratory syncytial virus (HRSV) glycoproteins were depleted from a commercial immunoglobulin preparation (RespiGam) by two different methods. The first method consisted of repeated adsorption of RespiGam to Sepharose beads with covalently bound soluble forms of the two major viral glycoproteins (F or G). The second method consisted of adsorption of immunoglobulins to live cells expressing F or G glycoproteins on their surfaces after infection with vaccinia virus recombinants. While the first method removed efficiently antibodies that reacted with F and/or G glycoproteins by ELISA, it was inefficient in the elimination of anti-HRSV neutralizing antibodies. In contrast, the second method removed efficiently anti-HRSV antibodies that both reacted by ELISA and neutralized virus infectivity. These results confirm that human neutralizing antibodies are directed exclusively against HRSV F and G glycoproteins, and, they raise the possibility that F and G glycoproteins inserted into cell membranes differ antigenically from their soluble forms linked covalently to Sepharose beads.

Citing Articles

Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.

Terhuja M, Siddappa M, Lamichhane P, Meshram C, Snider T, Ritchey J Viruses. 2024; 16(6).

PMID: 38932136 PMC: 11209524. DOI: 10.3390/v16060843.


Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus.

Dimmock N, Easton A Viruses. 2023; 15(2).

PMID: 36851717 PMC: 9961721. DOI: 10.3390/v15020504.


Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins.

Hsieh C, Rush S, Palomo C, Chou C, Pickens W, Mas V Nat Commun. 2022; 13(1):1299.

PMID: 35288548 PMC: 8921277. DOI: 10.1038/s41467-022-28931-3.


SARS-CoV-2 spike conformation determines plasma neutralizing activity.

Bowen J, Walls A, Joshi A, Sprouse K, Stewart C, Tortorici M bioRxiv. 2022; .

PMID: 34981060 PMC: 8722597. DOI: 10.1101/2021.12.19.473391.


An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.

Dang H, Chan Y, Park Y, Snijder J, Da Silva S, Vu B Nat Struct Mol Biol. 2019; 26(10):980-987.

PMID: 31570878 PMC: 6858553. DOI: 10.1038/s41594-019-0308-9.